Pharmaceutical Technology

JANUARY 20, 2023

However, during the Covid-19 pandemic, the US-based biotech rose to prominence as it was one of the first companies to develop Covid-19 vaccines with its mRNA technology. billion in Covid-19 vaccine sales. Moderna’s Covid-19 vaccine Spikevax is an mRNA vaccine that can be adapted to new SARS-CoV-2 variants.

Manufacturing 98

Manufacturing Government Sales Pharmaceutical 98

Pharmaceutical Technology

AUGUST 23, 2022

5-adapted bivalent vaccine for Covid-19 in people aged 12 years and above. In July, the US FDA approved the companies’ supplemental Biologics License Application (sBLA) for their Covid-19 vaccine, Comirnaty, for use in adolescents aged 12 to 15 years. Topic sponsors are not involved in the creation of editorial content.

FDA 52

FDA Food and Drug Administration Distribution Manufacturing 52

Pharmaceutical Technology

AUGUST 24, 2022

5 Omicron-targeting bivalent booster vaccine for Covid-19. Moderna’s mRNA platform has enabled us to develop, study, and deploy bivalent booster vaccine candidates that demonstrate superior protection against all tested Covid variants in record time.”. Topic sponsors are not involved in the creation of editorial content.

FDA 52

FDA Food and Drug Administration Food Pharmaceutical 52

Clarivate

NOVEMBER 28, 2023

A Broad Range The latest compendium of fast-moving Research Fronts reflects a broad range of specialty areas and topics. Although studies related to COVID-19 have receded in comparison to their high profile in the previous two annual roundups, the pandemic and its various facets still command attention.

Specialization 59

Specialization Medicine Leads Government 59

Pharma Marketing Network

JUNE 4, 2020

Marketing is challenging in these days of COVID-19 because each person and business is experiencing the virus in different ways. Enable your entire team – no matter where they’re located – to create video updates that can be shared far and wide. All are impacted and all are (trying) to adapt. 4 Motivate.

Education 83

Education Marketing Networking Pharma 83

Clarivate

NOVEMBER 17, 2021

Women leaders at Clarivate like Ann Graul play a key role in accelerating innovation in the quest for answers to COVID-19 issues. The global COVID-19 pandemic that began in early 2020 turned the world as we knew it upside down, bringing unimagined challenges and exacerbating existing struggles. Watch their story.

Leads 59

Leads Medicine Patients Biopharma 59

Clarivate

JANUARY 3, 2023

The latest compendium of fast-moving Research Fronts reflects a wide range of specialty areas and topics. As with the 2021 edition, this year’s roundup conveys the broad and pervasive impact of COVID-19 on global research. A wide range. Fields and nations.

Specialization 98

Specialization Side effects Management Medicine 98

pharmaphorum

NOVEMBER 1, 2022

In 2023 we will see the return of SAE’s RNA Therapeutics conference to a live in-person event, showcasing an update on mRNA therapeutic applications, coupled with an industry outlook of the field. Further topics to be examined comprise of novel RNA modalities encompassing self-amplifying RNA, saRNA, circular RNA, lnc RNA and many more.

Pharmacology 52

Pharmacology Medicine Networking Pharma 52

pharmaphorum

SEPTEMBER 29, 2022

At the moment, treatment typically involves oral or topical corticosteroids, antihistamines, and some antidepressant drugs, but responses are often inadequate, vary widely between patients, and come with the burden of safety risks if used long-term. The post FDA clears Dupixent as first drug for rare skin disorder appeared first on.

FDA 69

FDA Patients Leads Safety 69

PM360

DECEMBER 14, 2023

Moderna Joins CEPI Pandemic Preparedness Mission After making its debut in the pharma market during the COVID-19 pandemic, Moderna is preparing for the next pandemic. Additionally, MedCentral offers diversity topics and points of view to ensure clinicians find the support they need.

Physicians 52

Physicians Pharma Medical Patients 52

Clarivate

DECEMBER 8, 2021

As in previous reports, the latest compendium of fast-moving Research Fronts reflects a broad range of specialty areas and topics. Most strikingly, the 2021 edition conveys the rapid and pervasive impact of COVID-19 on global research. A broad range. Fields and nations.

Specialization 98

Specialization Leads Government Medical 98

Copyright Clearance Center

SEPTEMBER 22, 2022

And little bit of updated information on the topics we covered: * Psychology, in particular, seems to have a replicability problem ; even outside of psych, everyone knows that bad papers are still getting published (and they may even have a discoverability advantage ).

Doctors 98

Doctors Media FDA 98

PM360

JUNE 11, 2022

While social media had already been on the rise for disseminating medical information, the COVID-19 pandemic pushed many healthcare providers (HCPs) into the space. What’s an important topic to you that you post about? What’s an important topic to you that you post about?

Media 52

Media Education Pharma Patients 52

pharmaphorum

JUNE 30, 2022

However, with COVID-19 re-emphasizing gaps in trial diversity and inclusion, there is a renewed focus on doing more, especially as we can leverage deep expertise and transformative technologies to knock down long-standing barriers.

Patients 64

Patients Recruitment Transportation Healthcare 64

European Pharmaceutical Review

AUGUST 17, 2022

Despite this toll, AMR has often been called the ‘silent pandemic’: 4 “AMR is sadly silent because it has not been discussed like other pandemics – and of course has been in the shadow of the COVID-19 pandemic in recent years,” commented Melissa Gong Mitchell, Secretariat Lead of the AMR Industry Alliance. About the author.

Manufacturing 92

Manufacturing Food and Drug Administration Management Pharmaceutical manufacturing 92

Medgadget

MAY 3, 2023

From the perspective of low hanging fruit, AI can be used to automate tedious administrative tasks such as scheduling appointments, updating medical records, or processing paperwork, saving clinicians time allow them to devote more of their efforts to direct patient care. Alice Ferng, Medgadget: Thank you for taking the time to talk to us!

Healthcare 81

Healthcare Healthcare Leads Medical 81

Pharmaceutical Technology

SEPTEMBER 1, 2022

The US Food and Drug Administration (FDA) has granted Emergency Use Authorizations (EUAs) for bivalent formulations of Moderna and Pfizer -BioNTech’s Covid-19 vaccines as boosters. Nonclinical data obtained using bivalent Covid-19 vaccines were included in the dataset. 5 lineage of the Omicron variant. 1 lineage.

FDA 104

FDA Food and Drug Administration Safety Food 104

PM360

OCTOBER 28, 2022

The impact of racism on medicine has frequently been the subject of headlines over the past few years, particularly during the COVID-19 pandemic, when federal regulators pushed for more inclusive enrollment in the vaccine trials, and societal calls to action to address systemic and structural racism became loud and clear.

Medical 98

Medical Medicine Recruitment Patients 98

Salesforce

APRIL 27, 2021

Updates on Our Latest COVID-19 Actions April 27, 2021 Throughout the pandemic, we at Salesforce have been deeply committed to providing support to our employees, customers, partners, and communities. India, home to over 4,000 Salesforce employees, is experiencing record high COVID-19 cases , with numbers reaching nearly 3.8

Safety 52

Safety Government Healthcare Healthcare 52

Med Device Careers

MARCH 18, 2022

COVID-19 helped to force some positive changes. COVID-19 has certainly presented a challenge for healthcare across the board. In this conversation, Beth and Amy explained how COVID served as the prevailing force for change to embrace technology and employ change for the greater good at Sanger. W e were wrong.

Patients 52

Patients Training Management Healthcare 52

Clarivate

AUGUST 9, 2022

In this latest update to our ongoing blog series, we look at research contributing to the United Nations Sustainable Development Goals (SDGs) with a specific focus on SDG 16: Peace, Justice and Strong Institutions. Unfortunately, these outcomes appear to only have been exacerbated as the COVID-19 pandemic rages on.

Government 98

Government Ethics Leads Media 98

Healthcare Success

JUNE 13, 2022

According to 2021 Zoom-Qualtrics Research, 61% of people who used virtual care during the COVID-19 pandemic said they want continued access to both virtual and in-person health services in the future. Engaging healthcare consumers with a personalized experience across every touchpoint is crucial in the post-COVID era.

Healthcare 98

Healthcare Healthcare Marketing Patients 98

Impetus Digital

NOVEMBER 23, 2023

Others might talk about the return of in-person meetings after the COVID-19 pandemic. Additional topics making the news include the increased focus on diversity and inclusion in the life science industry and clinical trial space, as well as sustainability.

Education 52

Education Healthcare Provider Physicians Pharma 52

Healthcare Success

MAY 24, 2022

Organic social media means posting photos, updates, events, etc., Related: Topical Social Media and YouTube webinar: COVID-19 and Healthcare Marketing. With the proper follow-up, consumers may be motivated to update their reviews to let others know you resolved the issue quickly.

Healthcare 104

Healthcare Healthcare Marketing Physicians 104

Healthcare Success

NOVEMBER 7, 2022

Keep Instagram users engaged and boost interactions by focusing on things like: Storytelling Trending topics Healthy-living tips Humor Pop-culture Memes. Consider the latest updates and changes in digital marketing . Hospitals and health systems have much more competition than at the start of the COVID-19 pandemic.

Marketing 52

Marketing Media Healthcare Healthcare 52

Pharmaceutical Technology

MARCH 1, 2023

Oragenics and Inspirevax have signed a license agreement to develop the former’s lead intranasal vaccine candidate for Covid-19, NT-CoV2-1. There is an unmet medical need for an intranasal Covid-19 vaccine. “We We are working diligently to advance the programme and intend to provide an update in mid-2023.”

Pharmaceutical 52

Pharmaceutical Safety Leads Medical 52